About Hospital Mutua de Terrassa
"Fundada l'any 1900, MútuaTerrassa és una entitat de benefici social que té per missió el servei a les persones, anticipant i resolent situacions i problemes relacionats amb la salut, l'autonomia personal o el seu benestar. Actua en l'àmbit geogràfic fonamentalment de Catalunya i en algunes activitats a tot el territori espanyol."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
11
Spanish Breast Cancer Research Group
11
Hospital Mutua de Terrassa
10
PETHEMA Foundation
10
Janssen Research & Development, LLC
7
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
4
Hospital Universitari Vall d'Hebron Research Institute
4
Agennix
3
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
3
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
3
Genentech, Inc.
3
Clinical Trials at Hospital Mutua de Terrassa
During the past decade, Hospital Mutua de Terrassa conducted 100 clinical trials. In the 10-year time frame, 100 clinical trials started and 37 clinical trials were completed, i.e. on
average, 37% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 21 clinical trials were completed. i.e. 70%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
1999-10-01
2013-04-01
Completed
460
FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients
2003-09-19
2013-10-01
Completed
1,925
Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer
1999-11-01
2007-12-01
Completed
1,289
EC Followed Docetaxel Versus ET Followed Capecitabine as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer
2004-02-01
2019-04-04
Completed
1,384
Sacral Nerve Stimulation for Anal Incontinence and Bowel Control
1998-11-01
2012-09-01
Completed
140
A Clinical Trial Assessing The Impact Of Inhaled Insulin On Glucose Control In Patients With Type 2 Diabetes Mellitus
2006-03-06
2008-02-19
Terminated
354
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hospital Mutua de Terrassa" #1 sponsor was "Pfizer" with 11 trials, followed by "Spanish Breast Cancer Research Group" with 11 trials
sponsored, "Hospital Mutua de Terrassa" with 10 trials sponsored, "PETHEMA Foundation" with 10 trials sponsored and "Janssen Research & Development, LLC"
with 10 trials sponsored. Other sponsors include 115 different institutions and
companies that sponsored additional 93 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Mutua de Terrassa"
#1 collaborator was "Hospital Mutua de Terrassa" with 5 trials as a collaborator, "Bristol-Myers Squibb" with 4 trials as a collaborator, "AstraZeneca" with 3 trials as a collaborator, "Hoffmann-La Roche" with 3 trials as a collaborator and "Pfizer" with 3 trials as a collaborator. Other collaborators include 134 different institutions and companies that were
collaborators in the rest 126 trials.
Clinical Trials Conditions at Hospital Mutua de Terrassa
According to Clinical.Site data, the most researched conditions in "Hospital Mutua de Terrassa" are
"Breast Cancer" (12 trials), "Multiple Myeloma" (8 trials), "Alzheimer Disease" (6 trials), "Alzheimer's Disease" (5 trials) and "Coronary Artery Disease" (4 trials). Many other conditions were trialed in "Hospital Mutua de Terrassa" in a lesser frequency.
Clinical Trials Intervention Types at Hospital Mutua de Terrassa
Most popular intervention types in "Hospital Mutua de Terrassa" are "Drug" (101 trials), "Other" (25 trials), "Procedure" (16 trials), "Device" (10 trials) and "Biological" (8 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (27 trials), "Lenalidomide" (8 trials), "Cyclophosphamide" (6 trials), "Dexamethasone" (6 trials) and "placebo" (6 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital Mutua de Terrassa
The vast majority of trials in "Hospital Mutua de Terrassa" are
146 trials for "All" genders, 20 trials for "Female" genders and 3 trials for "Male" genders.
Clinical Trials Status at Hospital Mutua de Terrassa
Currently, there are NaN active trials in "Hospital Mutua de Terrassa".
2 are not yet recruiting,
25 are recruiting,
16 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 90 completed trials in Hospital Mutua de Terrassa,
2 suspended trials,
and 22 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Mutua de Terrassa, 4 "Phase 1"
clinical trials were conducted, 33 "Phase 2" clinical
trials and 60 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 11 trials, and there were
also 18 trials that are defined as “Not Applicable".
Departments of Hospital Mutua de Terrassa
Hospital Mutua de Terrassa has several departments that took part in Clinical trials: "Hospital Mutua De Terrasa; Servicio de Neurologia" - 7 trials, "Hospital Mutua de Terrassa Servicio de Oncologia" - 4 trials, "Hospital Mutua de Terrassa; Servicio de Hematologia" - 3 trials, "ES-Barcelona-MUTUATERRASSA" - 2 trials
Departments List
Name
City
Trials